Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Sep 23, 2025

BUY
$9.02 - $10.67 $270,600 - $320,100
30,000 New
30,000 $309 Million
Q2 2024

Sep 24, 2025

SELL
$8.01 - $8.64 $4,806 - $5,184
-600 Reduced 1.96%
30,000 $248 Million
Q1 2024

Sep 24, 2025

BUY
$8.02 - $8.67 $245,412 - $265,302
30,600 New
30,600 $260 Million
Q3 2023

Oct 01, 2025

SELL
$7.85 - $8.94 $3,571 - $4,067
-455 Reduced 43.13%
600 $5 Million
Q1 2023

Oct 01, 2025

BUY
$7.57 - $8.37 $7,986 - $8,830
1,055 New
1,055 $8.59 Million
Q3 2022

Oct 01, 2025

BUY
$5.63 - $7.5 $7,921 - $10,552
1,407 New
1,407 $8.57 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Caldwell Trust CO Portfolio

Follow Caldwell Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caldwell Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Caldwell Trust CO with notifications on news.